Kre-Alkalyn® Research Article Published In Emory University School Of Medicine Peer-Reviewed Journal

Science For Humans #1743: SARMs 101
Science For Humans #1743: SARMs 101
October 21, 2015
Science For Humans #1748: The Thin Line Between Losing Body Fat And Maintaining Muscle
Science For Humans #1748: The Thin Line Between Losing Body Fat And Maintaining Muscle
October 28, 2015
Show all

Kre-Alkalyn® Research Article Published In Emory University School Of Medicine Peer-Reviewed Journal

Billings-based All American Pharmaceutical is pleased to announce that Dr. Jeff Golini’s research article, “The Effect of an Alkaline Buffered Creatine (Kre-Alkalyn®), on Cell Membrane Behavior, Protein Synthesis, And Cisplatin-Mediated Cellular Toxicity”, has been published by Integrative Molecular Medicine, through Emory University School of Medicine. Three previous research articles authored by Dr. Golini have appeared in other respected peer-reviewed journals.

Integrative Molecular Medicine (IMM) is a peer-reviewed, online open access journal dedicated to a new research discipline at the interface between clinical research and basic biology.

Dr. Golini serves as Executive Scientist for All American Pharmaceutical, a cutting-edge contract manufacturing and research facility that develops novel nutritional compounds and sports supplements, such as Kre-Alkalyn and Karbolyn, while also conducting research to promote improved human health and performance.

“Emory University maintains one of the finest medical schools in our nation. Having my research efforts recognized through one of their peer-reviewed journals is an honor”, states Dr. Golini, “and represents yet another significant milestone for All American Pharmaceutical.”

AAP
AAP
We are a contract manufacturer who transforms raw materials into dietary supplements that create trust, loyalty, and repeat sales.

Comments are closed.